PAVmed Inc. (PAVM)
NASDAQ: PAVM · Real-Time Price · USD
10.15
+0.09 (0.89%)
Mar 3, 2026, 4:00 PM EST - Market closed
PAVmed Revenue
PAVmed had revenue of $5.00K in the quarter ending September 30, 2025, a decrease of -99.50%. This brings the company's revenue in the last twelve months to $29.00K, down -99.28% year-over-year. In the year 2024, PAVmed had annual revenue of $3.00M with 22.15% growth.
Revenue (ttm)
$29.00K
Revenue Growth
-99.28%
P/S Ratio
500.12
Revenue / Employee
$744
Employees
39
Market Cap
14.50M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.00M | 543.00K | 22.15% |
| Dec 31, 2023 | 2.45M | 2.08M | 550.40% |
| Dec 31, 2022 | 377.00K | -123.00K | -24.60% |
| Dec 31, 2021 | 500.00K | - | - |
| Dec 31, 2020 | - | - | - |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Trinity Biotech | 48.57M |
| Lifeward | 24.50M |
| Vivos Therapeutics | 17.32M |
| Beyond Air | 6.92M |
| Tenon Medical | 3.23M |
| Sintx Technologies | 1.27M |
| Movano | 500.00K |
| Adagio Medical Holdings | 137.00K |
PAVM News
- 27 days ago - PAVmed Closes Preferred Stock and Senior Secured Note Financings, Eliminating All Previously Outstanding Convertible Securities - PRNewsWire
- 5 weeks ago - Should you chase the rally in PAVmed stock after it quadrupled on Wednesday? - Invezz
- 5 weeks ago - Lucid Diagnostics Awarded U.S. Department of Veterans Affairs Contract for EsoGuard® - PRNewsWire
- 2 months ago - PAVmed Announces Reverse Stock Split - PRNewsWire
- 3 months ago - Lucid Diagnostics Announces Positive Data from the Largest Reported Real-World Experience of Esophageal Precancer Detection - PRNewsWire
- 3 months ago - PAVmed Inc. (PAVM) Shareholder/Analyst Call Prepared Remarks Transcript - Seeking Alpha
- 3 months ago - Lucid Diagnostics Named a GenomeWeb 2025 Best Places to Work Top-Ranking Honoree - PRNewsWire
- 3 months ago - PAVmed Inc. (PAVM) Q3 2025 Earnings Call Transcript - Seeking Alpha